Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

NCT00985673 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

611

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GSK2340274A
BIOLOGICAL: GSK2340273A
BIOLOGICAL: Seasonal trivalent influenza vaccine (TIV)
BIOLOGICAL: Saline placebo

Sponsor

GlaxoSmithKline